Minimize Risks in Late-Stage Projects Through Quality Partner Selection

This webcast features: Pramthesh Patel, Vice President, Process Development, Avid Bioservices.

The development and delivery of pharmaceutical drugs require a complex process involving stringent clinical assessments and CMC packaging considerations. CDMOs play a crucial role in manufacturing drugs and meeting CMC requirements and timelines.

However, recent changes in the CDMO landscape and geopolitical uncertainties have raised concerns about their ability to meet these obligations.

This case study highlights Avid Bioservices' ability to address challenges for clients with late-stage projects at other CDMOs. Issues with timeline adherence and CGMP compliance led clients to seek alternative solutions. Avid facilitated a seamless tech transfer, integrated the projects into their facilities, and executed a process performance qualification (PPQ) campaign without major setbacks, achieving an on-time product launch.

Key Takeaways:

Just fill out the form below to watch the recorded webcast now.